Gemini, Sequenom Shareholders Approve Merger; September Close Sought

Aug 24, 2001

NEW YORK, Aug. 24 – Shareholders of UK-based Gemini Genomics and US-based Sequenom have approved the firms’ plans to merge, the companies said on Thursday.

The combined company, which will retain the name Sequenom, must still obtain approval from the High Court of Justice in England and Wales. The companies anticipate the deal to close at the end of September.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Main menu